LAINGAX
Dead / Abandoned — Abandoned — no statement of use filed (as of 15 Oct 2025)
What this means for you
This application is over — abandoned 15 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90717653
- Mark type
- Stylized text
- Filed
- 18 May 2021
- Published for opposition
- 08 Mar 2022
- Abandoned
- 15 Oct 2025
- Attorney of record
- GABRIELLE S. ROTH
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for use in stimulating white blood cell production and pharmaceutical preparations for the treatment of cancer and of blood disorders and conditions, including those caused by cancer treatments
Owner
- Tanvex BioPharma, Inc., Grand Cayman, KY
- Tanvex BioPharma, Inc., Grand Cayman, KY
Prosecution history
- 15 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 15 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 31 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Oct 2024 — SOU EXTENSION 5 GRANTED
- 31 Oct 2024 — SOU EXTENSION 5 FILED
- 31 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 27 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Apr 2024 — SOU EXTENSION 4 GRANTED
- 26 Apr 2024 — SOU EXTENSION 4 FILED
- 26 Apr 2024 — SOU TEAS EXTENSION RECEIVED
- 04 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Nov 2023 — SOU EXTENSION 3 GRANTED
- 02 Nov 2023 — SOU EXTENSION 3 FILED
- 02 Nov 2023 — SOU TEAS EXTENSION RECEIVED
- 19 Apr 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED